Lack of Benefit From Paracetamol (Acetaminophen) for Palliative Cancer Patients Requiring High-Dose Strong Opioids: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

Journal of Pain and Symptom Management

Volumn 39, Issue 3, 2010, Pages 548-554

  Israel, Fiona J ^a,b,c,d   Parker, Greg ^a,b   Charles, Margaret ^e   Reymond, Liz ^a,b,c,d  

^a Brisbane South Palliative Care Service   (Australia)

^b QUEENSLAND HEALTH   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d Mt Olivet Hospital   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

acetaminophen; cancer; high dose opioids; Pain; palliative care; paracetamol; strong opioids

Indexed keywords

MORPHINE; PARACETAMOL; PLACEBO;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; MALE; NAUSEA; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; VOMITING; WELLBEING;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN; PALLIATIVE CARE;

EID: 77949469671     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2009.07.008     Document Type: Article

References (14)

1. World Health Organization. Cancer pain relief (1986), World Health Organization, Geneva, Switzerland
2. World Health Organization. Palliative cancer pain: Pain relief and management of other symptoms (1992), World Health Organization Publications Centre, Geneva, Switzerland
3. Axelsson B., Stellborn P., and Strom G. Analgesic effect of paracetamol on cancer related pain in concurrent strong opioid therapy. A prospective clinical study. Acta Oncol 47 (2008) 891-895
4. McNicol E.D., Strassels S., Goudas L., Lau J., and Carr D.B. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev 2 (2005) 10.1002/14651858.CD005180
5. Filitz J., Ihmsen H., Gunther W., et al. Supra-additive effects of tramadol and acetaminophen in a human pain model. Pain 136 (2008) 262-270
6. Frickle J.R., Hewitt D.J., Jordan D.M., Fisher A., and Rosenthal N.R. A double-blind placebo-controlled comparison of tramadol/acetaminophen and tramadol in patients with postoperative dental pain. Pain 109 (2004) 250-257
7. Axelsson B., and Christensen S.B. Is there an additive analgesic effect of paracetamol at step 3? A double-blind randomized controlled study. J Palliat Med 18 (2003) 724-725
8. Stockler M., Vardy J., Pillai A., and Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomised, double-blind, placebo-controlled cross-over trial. J Clin Oncol 22 (2004) 3389-3394
9. Hardy J., Reymond E., and Charles M. Acetaminophen in cancer pain. J Clin Oncol 23 (2005) 1586
10. Farrar J.T., Berlin J.A., and Strom B.L. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage 25 (2003) 406-411
11. Kendrick D.B., and Strout T.D. The minimum clinically significant difference in patient-assigned numeric scores for pain. Am J Emerg Med 23 (2005) 828-832
12. Hojat M., and Xu G. A visitor's guide to effect sizes-Statistical significance versus practical (clinical) importance of research findings. Adv Health Sci Educ Theory Pract 9 (2004) 241-249
13. Altman D.G. Practical statistics for medical research (1991), Chapman & Hall/CRC, Boca Raton, FL
14. Bennett M.I. Principles of designing clinical trials in palliative care. In: Addington-Hall J.M., Bruera E., Higginson I., and Payne S. (Eds). Research methods in palliative care (2007), Oxford University Press, Oxford, UK 13-26